Virus-encoded modulators of cytokines and growth factors

Cytokine and Growth Factor Reviews

Volumn 10, Issue 1, 1999, Pages 1-4

  Spriggs, Melanie K ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GROWTH FACTOR; GROWTH PROMOTOR; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; TUMOR NECROSIS FACTOR;

ADAPTATION; ANIMAL; ANTIBODY PRODUCTION; B LYMPHOCYTE; COMPLEMENT FIXATION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; GENETIC CODE; GENETICS; HERPES VIRUS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; NATURAL KILLER CELL; NONHUMAN; POXVIRUS; REVIEW; VIRUS GENE; VIRUS INFECTION;

ANIMALIA; HERPES; HERPESVIRIDAE; POXVIRIDAE;

EID: 0033103097     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00021-5     Document Type: Short Survey

References (33)

1. Spriggs M.K. One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 14:1996;101-130.
2. Farrell H.E., Davis-Poynter N.J. From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cell-mediated immunity. Semin. Cell Dev. Biol. 9:1998;369-378.
3. Cuff S., Ruby J. Evasion of apoptosis by DNA viruses. Immunol. Cell Biol. 74:1996;527-537.
4. Wiertz E., Hill A., Tortorella D., Ploegh H. Cytomegaloviruses use multiple mechanisms to elude the host immune response. Immunol. Lett. 57:1997;213-216.
5. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253.
6. Smith G.L., Symons J.A., Alcamí A. Poxviruses: interfering with interferon. Semin. Virol. 8:1998;409-418.
7. Pease J.E., Murphy P.M. Microbial corruption of the chemokine system: an expanding paradigm. Semin. Immunol. 10:1998;169-178.
8. Stuart A.D., Stewart J.P., Arrand J.R., Mackett M. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes. Oncogene. 11:1995;1711-1719.
9. Ho A.S-Y., Moore K.W. Interleukin-10 and its receptor. Ther. Immunol. 1:1994;173-185.
10. Liu Y., de Waal Malefyt R., Briere F., Parham C., Bridon J-M., Banchereau J., Moore K.W., Xu J. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. J. Immunol. 158:1997;604-613.
11. Kotenko S.V., Krause C.D., Izotova L.S., Pollack B.P., Wu W., Pestka S. Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J. 16:1997;5894-5903.
12. Moghaddam A., Rosenzweig M., Lee-Parritz D., Annis B., Johnson R.P., Wang F. An animal model for acute and persistent Epstein-Barr virus infection. Science. 276:1997;2030-2033.
13. Stroobant P., Rice A.P., Gullick W.J., Cheng D.J., Kerr I.M., Waterfield M.D. Purification and characterization of vaccinia virus growth factor. Cell. 42:1985;383-393.
14. Twardzik D.R., Brown J.P., Ranchalis J.E., Todaro G.J., Moss B. Vaccinia virus infected cells release a novel polypeptide functionally related to EGF. Proc. Natl. Acad. Sci. USA. 82:1985;5300-5304.
15. King C.S., Cooper J.A., Moss B., Twardzik D.R. Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors. Mol. Cell. Biol. 6:1986;332-336.
16. Upton C., Macen J.L., McFadden G. Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha. J. Virol. 61:1987;1271-1275.
17. Chang W., Upton C., Hu S.L., Purchio A.F., McFadden G. The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha. Mol. Cell. Biol. 7:1987;535-540.
18. Tzahar E., Moyer J.D., Waterman H., Barbacci E.G., Bao J., Levkowitz G., Shelly M., Strano S., Pinkas-Kramarski R., Pierce J.H., Andrews G.C., Yarden Y. Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J. 17:1998;5948-5963.
19. Rouvier E., Luciani M.F., Mattéi M.G., Denizot F., Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150:1993;5445-5456.
20. Antonysamy M.A., Fanslow W.C., Fu F., Li W., Qian S., Troutt A.B., Thomson A.W., Evidence of a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors, J. Immunol. (in press).
21. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., Cohen J.I., Spriggs M.K. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 3:1995;811-821.
22. Lubinski J.M., Wang L., Soulika A.M., Burger R., Wetsel R.A., Colten H., Cohen G.H., Eisenberg R.J., Lambris J.D., Friedman H.M. Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J. Virol. 72:1998;8257-8263.
23. McFadden G., Lalani A., Everett H., Nash P., Xu X. Virus-encoded receptors for cytokines and chemokines. Semin. Cell Dev. Biol. 9:1998;359-368.
24. Nagashunmugam T., Lubinski J., Wang L., Goldstein L.T., Weeks B.S., Sundaresan P., Kang E.H., Dubin G., Friedman H.M. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J. Virol. 72:1998;5351-5359.
25. Smith G.L., Symons J.A., Khanna A., Vanderplasschen A., Alcamí A. Vaccinia virus immune evasion. Immunol. Rev. 159:1997;137-154.
26. Alcamí A., Symons J.A., Collins P.D., Williams T.J., Smith G.L. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:1998;624-633.
27. Smith C.A., Smith T.D., Smolak P.J., Friend D., Hagen H., Gerhart M., Park L., Pickup D.J., Torrance D., Mohler K., Schooley K., Goodwin R.G. Poxvirus genomes encode a secreted, soluble protein that completely inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 236:1997;316-327.
28. Strockbine L.D., Cohen J.I., Farrah T., Lyman S.D., Wagener F., Dubose R.F., Armitage R.J., Spriggs M.K. The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor. J. Virol. 72:1998;4015-4021.
29. Zilli D., Voelkel-Johnson C., Skinner T., Laster S.M. The adenovirus E3 region 14.7 kDa protein, heat and sodium arsenite inhibit the TNF-induced release of arachidonic acid. Biochem. Biophys. Res. Commun. 188:1992;177-183.
30. Li Y., Kang J., Horwitz M.S. Interaction of an adenovirus 14.7-kilodalton protein inhibitor of tumor necrosis factor alpha cytolysis with a new member of the GTPase superfamily of signal transducers. J. Virol. 71:1997;1576-1582.
31. Li Y., Kang J., Horwitz M.S. Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol. Cell. Biol. 18:1998;1601-1610.
32. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P.J., Sherry B., Trinchieri G., Griffin D.E. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:1996;228-231.
33. Ray R.B., Meyer K., Steele R., Shrivastava A., Aggarwal B.B., Ray R. Inhibition of tumor necrosis factor (TNF-α)-mediated apoptosis by hepatitis C virus core protein. J. Biol. Chem. 273:1998;2256-2259.